Clinical utility of oral Nemonoxacin 500 mg once daily for the treatment of acute lower urinary tract infections: a prospective open-label, multicenter study

Clinical utility of oral Nemonoxacin 500 mg once daily for the treatment of acute lower urinary tract infections: a prospective open-label, multicenter study

Abstract Background Urinary tract infection (UTI) is one of the most common infectious diseases requiring convenient and appropriate treatment. Nemonoxacin is active against the common pathogens of UTIs. However, more clinical data are required to further support the utility of 500 mg nemonoxacin on...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhen Du, Bo Zheng, Shan Chen, Liang Cui, Huilin Wu, Zhan Gao, Jin Yang, Gang Cui, Jiajing Wang, Tiehuan Shu, Ninghan Feng, Ludong Qiao
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Infectious Diseases
Subjects:
Nemonoxacin
Oral administration
Acute lower urinary tract infection
Clinical efficacy
Prospective clinical trial
Online Access:https://doi.org/10.1186/s12879-025-10915-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12879-025-10915-5

Similar Items